Pricing Log in Create free account

Stoke Therapeutics, Inc. (STOK) vs Zenas BioPharma, Inc. (ZBIO)

Stoke Therapeutics, Inc. and Zenas BioPharma, Inc. are both Biotechnology companies. Stoke Therapeutics, Inc. and Zenas BioPharma, Inc. are of similar size ($1.7B and $1.7B). Zenas BioPharma, Inc. has the higher net margin (−763.1% vs −862.1%) and the higher return on invested capital (0.00% vs −482.0%). Across the 14 metrics below, Zenas BioPharma, Inc. leads on 8 and Stoke Therapeutics, Inc. on 6.

Valuation

Metric STOK ZBIO Biotechnology median
P/E n/m n/m 10.60
P/S 64.12 26.29 9.40
P/B 5.13 8.79 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 52.81 23.52 9.02
Earnings yield (14.35%) (33.38%) (32.88%)
Free cash flow yield (11.93%) (13.01%) (23.13%)

Profitability

Metric STOK ZBIO Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (913.12%) (741.41%) 0.00%
Net margin (862.07%) (763.11%) 0.00%
Free cash flow margin (764.66%) (342.02%) 0.00%
Return on equity (73.62%) (265.11%) (51.96%)
Return on assets (63.42%) (108.66%) (46.06%)
Return on invested capital (482.02%) 0.00% 0.00%

Growth

Metric STOK ZBIO Biotechnology median
Revenue growth (TTM) (86.28%) — 6.76%
EPS growth (last fiscal year) 92.73% 29.04% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric STOK ZBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.24 9.42 4.97
Net debt to EBITDA 14.29 0.69 1.01

Dividend

Metric STOK ZBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric STOK ZBIO Biotechnology median
Market cap 1.71b 1.69b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack